Applying mean systemic filling pressure to assess the response to fluid boluses in cardiac post-surgical patients

Intensive Care Med. 2015 Feb;41(2):265-72. doi: 10.1007/s00134-014-3611-2. Epub 2015 Jan 8.

Abstract

Purpose: To evaluate an analogue of mean systemic filling pressure (P(msa)) and derived variables to quantitatively assess the effectiveness of volume expansion in increasing cardiac output.

Methods: Sixty-one cardiac post-surgical patients were studied and 107 fluid boluses were captured. Cardiac output, mean arterial pressure and right atrial pressure were recorded with P msa before and after a bolus fluid. An increase in cardiac output greater than 10 % following a fluid bolus defined a patient as a responder. Cardiac power (i.e. the product of arterial pressure and cardiac output) and P(msa) to right atrial pressure gradient (i.e. the driving pressure for venous return and hence cardiac output) were evaluated to assess the efficiency of volume expansion to increase cardiac output. Cardiac power relative to P(msa) (CP(vol)), its dynamic changes and the dynamic changes in P msa-right atrial pressure gradient relative to the P(msa) change (E(vol)) were investigated.

Results: CP(vol) was lower and E(vol) was higher in responders vs. non-responders. Furthermore, in patients receiving a second fluid bolus, E(vol) correlated with the degree of increase in cardiac output. Multivariate regression analysis identified both CP(vol) and E(vol) as independent variables associated with volume responsiveness.

Conclusions: Using an algorithm to derive a mean systemic filling pressure analogue, cardiac power and dynamic measures of the venous return pressure gradient relative to the mean systemic filling pressure provided an assessment of the efficiency of volume expansion in post-surgical cardiac patients.

MeSH terms

  • Aged
  • Blood Pressure / physiology*
  • Blood Volume
  • Cardiac Output / physiology*
  • Cardiac Surgical Procedures
  • Female
  • Fluid Therapy / methods*
  • Hemodynamics / physiology*
  • Humans
  • Male
  • Middle Aged
  • Plasma Substitutes / therapeutic use*
  • Postoperative Period
  • Regression Analysis

Substances

  • Plasma Substitutes